Back
ESC Professional Premium Access

Plasma CCL3 predicts adverse heart failure outcomes in patients with arrhythmogenic cardiomyopathy

Session: Mechanisms and management of cardiomyopathies
Topic: Biomarkers
Speaker: Doctor T. Yang (Beijing, CN)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Tianshuo Yang

Fuwai Hospital, CAMS and PUMC, Beijing (China)
0 follower

6 more presentations in this session

Psychiatric disorders in Takotsubo syndrome: clinical profiles and outcomes

Speaker: Doctor D. Di Vece (Greifswald, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Long-term outcomes of treatment strategies for ischemic cardiomyopathy, a network meta-analysis

Speaker: Mr D. Perez Camargo (Madrid, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

Racial differences in obstetric complications associated with peripartum cardiomyopathy and time to presentation

Speaker: Miss K. Sompel (Aurora, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Myocardial work impact in the evaluation of advanced heart failure

Speaker: Doctor L. Martini (Siena, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Identifying racially inequities driven by social determinants of health in US peripartum cardiomyopathy patients and the influence on time to presentation

Speaker: Miss K. Sompel (Aurora, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Mechanisms and management of cardiomyopathies

Speakers: Doctor T. Yang, Doctor D. Di Vece, Mr D. Perez Camargo, Miss K. Sompel, Doctor L. Martini...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources